Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Articles
    4. Protectability of AI diagnostics in health care

      Articles

    Article

    Protectability of AI diagnostics in health care

    July 16, 2020

    LinkedInX (Twitter)EmailCopy URL
    Health care innovators continue to develop artificial intelligent algorithms. While these algorithms are very valuable, they are tricky to protect as intellectual property.

    Health care innovators continue to develop artificial intelligent (AI) algorithms to aid them in diagnosing and treating patients. However, while these algorithms are very valuable, they are tricky to protect as intellectual property.

    Many companies in fields outside health care protect their AI algorithms with trade secrets because they innovate too fast for patents to be worthwhile. They would not be able to detect when competitors are infringing anyway. But in the case of health care, particularly diagnostics, algorithms must be verified by doctors and regulators—so trade secret protection gets complicated, as at least part of the algorithms might need to be disclosed.

    Since trade secrets are not an option to fully protect them, companies must develop another way to sufficiently protect their algorithms to justify the cost of clinical trials. As a result, the only option is to patent. Unless the government makes significant changes, AI-based diagnostics will continue to be tricky to patent, since software and diagnostic patent laws are constantly evolving.

    But with some legal creativity, there are multiple paths to patent protection for AI-based diagnostics. As opposed to technology that resides in a field, the combination of software and diagnostics can actually be easier to patent because it relies on patent laws originating in both the software and biotech fields.

    First, since many diagnostics require sensors, algorithms can be patented if tied to the use of specific sensors, like, for example, pulse oximeters. This is one avenue health care companies typically use to overcome software patentability obstacles. In cases where diagnostics do not require sensors, the patents can be tied to a particular treatment once there is a diagnosis—one of the classic linchpins for patenting in the biotech space. In many cases, having both types of patents also provides better protection than would be available for either only software or diagnostics.

    Second, the details of algorithms can still be kept as trade secrets. Particularly, the training data and further details can generally be kept secret and even provide a competitive advantage. Trade secret protection, combined with unique patenting strategies, usually provides sufficient protection for AI-based diagnostics. Therefore, health care companies would be wise to develop AI-based diagnostics and precision medicine tools, but carefully craft their IP strategy using patents to fully protect these innovations.

    Practices

    Intellectual PropertyLife Sciences
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved